Alkermes plc. Fair Value Adjustment of Warrants
Alkermes plc. (ALKS) reported Fair Value Adjustment of Warrants of $400.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2018-02-16
- Alkermes plc. fair value adjustment of warrants for the quarter ending 2016-12-31 was $100.00K, a 88.89% decline year-over-year.
- Alkermes plc. fair value adjustment of warrants for the quarter ending 2016-09-30 was -$200.00K, a 166.67% decline year-over-year.
- Alkermes plc. fair value adjustment of warrants for the quarter ending 2016-06-30 was -$400.00K.
- Alkermes plc. fair value adjustment of warrants for the quarter ending 2016-03-31 was $800.00K.
- Alkermes plc. fair value adjustment of warrants for fiscal 2016 was $400.00K, a 33.33% increase from fiscal 2015.
- Alkermes plc. fair value adjustment of warrants for fiscal 2015 was $300.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$100.00K derived: sum of 2 quarters · filed 2018-02-16 | -$500.00K derived: sum of 3 quarters · filed 2018-02-16 | $400.00K 10-K · filed 2018-02-16 | ||||
| 2016-09-30 | -$200.00K 10-Q · filed 2016-11-02 | -$600.00K derived: sum of 2 quarters · filed 2016-11-02 | $300.00K 10-Q · filed 2016-11-02 | $1.10M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | -$400.00K 10-Q · filed 2016-07-28 | $400.00K 10-Q · filed 2016-07-28 | $1.30M derived: sum of 3 quarters · filed 2018-02-16 | $1.60M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $800.00K 10-Q · filed 2017-04-27 | -$800.00K 10-Q · filed 2016-04-28 | $1.70M derived: sum of 2 quarters · filed 2018-02-16 | $2.00M derived: sum of 3 quarters · filed 2018-02-16 | $1.10M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.20M derived: sum of 2 quarters · filed 2018-02-16 | $300.00K derived: sum of 3 quarters · filed 2018-02-16 | $300.00K 10-K · filed 2018-02-16 | -$300.00K 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $300.00K 10-Q · filed 2016-11-02 | -$300.00K 10-Q · filed 2015-10-29 | -$600.00K derived: sum of 2 quarters · filed 2016-11-02 | -$600.00K 10-Q · filed 2016-11-02 | $600.00K 10-Q · filed 2015-10-29 | |||
| 2015-06-30 | -$900.00K 10-Q · filed 2016-07-28 | -$900.00K 10-Q · filed 2016-07-28 | $900.00K 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |